Healio
FDA approves Johnson & Johnson’s Tecnis PureSee IOL
The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...
Ophthalmology Times
FDA approves Johnson & Johnson's TECNIS PureSee EDOF IOL
According to the company, the lens is the first and only FDA-approved EDOF IOL in the US without a warning regarding loss of contrast sensitivity. Johnson & Johnson announced that the US Food and Drug ...
SCIENTURE Broadens Commercial Access for REZENOPY(TM), Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions
Expands institutional footprint with potential penetration of more than 60% of the U.S. market, while expanding reach across EMS providers and rehabilitation centers U.S. naloxone market totals $141M ...
J&J wins FDA nod for Tecnis PureSee intraocular lens
Johnson & Johnson (JNJ) wins FDA approval for Tecnis PureSee intraocular lens ((IOL)), giving eye surgeons a new lens option for use in cataract surgery. Read more here.
MassDevice
Johnson & Johnson wins FDA nod for new intraocular lens
The Tecnis PureSee IOL. [Image courtesy of J&J] Johnson & Johnson (NYSE: JNJ) + announced today that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery. The ...